Loading…
You need a Twin Cities Startup Week Ticket to register for events.

If an event is listed as "*EXTERNAL REGISTRATION REQUIRED*" you must visit that event’s external registration page to secure your spot.
Back To Schedule
Monday, October 14 • 1:30pm - 2:30pm
Exponential Medicine

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
Minnesota is home to some of the most innovative and successful health care companies in the world, as well as a vibrant ecosystem of startups. How are they using exponential tech- the technologies poised for exponential impact and adoption? In this session, we’ll have 3 speakers that are leading exponential innovations in health care share their stories and perspectives about the opportunity they see in leveraging these new exponential technologies (e.g. digital biology, AI, blockchain, digital manufacturing, etc.) in health care.

Moderators
avatar for Ryan Weber

Ryan Weber

Ryan Weber is Managing Partner at Great North Labs, an early-stage venture fund focused on the Upper Midwest. He is also Co-Ambassador for SingularityU Minneapolis-St. Paul, and an active advisor, mentor, and speaker on tech entrepreneurship, startup ecosystems, and exponential technologies... Read More →

Speakers
avatar for Ryan Gordon

Ryan Gordon

VP Business Development and Commercialization, StemoniX
Ryan Gordon is VP Business Development and Commercialization at StemoniX, a company that makes human brains to enable medicines to be safer and more effective. The company helps the world’s leading therapeutic companies design new medicines faster and more accurately and reduce... Read More →
avatar for Thomas Gilbert

Thomas Gilbert

Vice President of Research & Development, Miromatrix Medical Inc.
Thomas Gilbert is Vice President of Research & Development for Miromatrix Medical Inc., a biotechnology company developing and commercializing next generation biologic-based therapeutics and transplantable organs using on Miromatrix’s patented perfusion decellularization and recellularization... Read More →
avatar for Mark Platt

Mark Platt

Mark Platt is CEO of Recombinetics, a global leader in proprietary gene repair and gene-editing technology whose breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing technologies has resulted in breakthroughs in the regenerative medicine, disease... Read More →

Monday October 14, 2019 1:30pm - 2:30pm CDT
Junior Achievement of the Upper Midwest
  Healthcare Track

Attendees (69)